bempedoic acid/ezetimibe
Brand names: Nexlizet
Nexlizet is a combination medicine that helps lower cholesterol. It is used with diet and exercise to lower LDL-C (bad cholesterol) in adults.
Drug Pricing (NADAC)
Brand Price
$13.05/unit
Generic Available
No
Pricing data from NADAC (CMS), effective December 18, 2024. Compare all drug costs →
What it does
Nexlizet is used to lower LDL-C (bad cholesterol) in adults who have high cholesterol.
Common side effects
Upper respiratory tract infection (like a cold), Muscle spasms, High uric acid levels in the blood
Key warnings
This medicine can raise uric acid levels in your blood, which can cause gout.
How It Works
Nexlizet contains two medicines that work in different ways to lower cholesterol. Bempedoic acid blocks an enzyme in your liver that makes cholesterol. Ezetimibe stops your body from absorbing cholesterol from food.
How to Take It
Take one Nexlizet tablet each day. You can take it with or without food. Swallow the tablet whole with a glass of water. If you miss a dose, take it as soon as you remember. But do not take two doses at the same time.
Pregnancy & Breastfeeding
This medicine may harm your unborn baby. Do not take Nexlizet if you are pregnant or planning to become pregnant. Talk to your doctor about other ways to lower your cholesterol during pregnancy.
Missed Dose
If you miss a dose, take it as soon as you remember. Do not take two doses at the same time to make up for the missed dose.
Storage
Store Nexlizet at room temperature, between 68°F to 77°F (20°C to 25°C), in the original package, away from heat and humidity. Keep the desiccant in the bottle.
Side Effects (from patient reports)
Based on 329 FDA adverse event reports.
Serious Warnings
This medicine can raise uric acid levels in your blood, which can cause gout. Tell your doctor if you have symptoms of high uric acid, like joint pain or swelling. Nexlizet can also increase your risk of tendon rupture. Stop taking Nexlizet and call your doctor right away if you have tendon pain, swelling, or difficulty moving.
Known Drug Interactions
Clinically Important Drug Interactions with NEXLIZET Simvastatin Clinical Impact: Concomitant use of NEXLIZET with simvastatin causes an increase in simvastatin concentration and may increase the risk of simvastatin-related myopathy [see Clinical Pharmacology (12.3) ] . Intervention: Avoid concomitant use of NEXLIZET with simvastatin greater than 20 mg. Simvastatin: Avoid concomitant use of NEXLIZET with simvastatin greater than 20 mg.
Mechanism: Taking these together can cause simvastatin levels to rise in your body, which may lead to muscle pain or weakness.
What to do: Avoid taking more than 20 mg of simvastatin daily when using this medication.
Pravastatin Clinical Impact: Concomitant use of NEXLIZET with pravastatin causes an increase in pravastatin concentration and may increase the risk of pravastatin-related myopathy [see Clinical Pharmacology (12.3) ] . Intervention: Avoid concomitant use of NEXLIZET with pravastatin greater than 40 mg. ( 7 ) Pravastatin: Avoid concomitant use of NEXLIZET with pravastatin greater than 40 mg.
Mechanism: This medicine can raise the levels of pravastatin in your blood, which may lead to muscle pain or weakness.
What to do: Avoid taking more than 40 mg of pravastatin daily when using this medication.
Fibrates Clinical Impact: Both fenofibrate and ezetimibe (a component of NEXLIZET) may increase cholesterol excretion into the bile, leading to cholelithiasis. Coadministration of NEXLIZET with fibrates other than fenofibrate is not recommended [see Adverse Reactions (6.1) ] . Intervention: If cholelithiasis is suspected in a patient receiving NEXLIZET and fenofibrate, gallbladder studies are indicated and alternative lipid-lowering therapy should be considered.
Mechanism: Both of these medicines can increase the amount of cholesterol that moves into the bile, which may cause gallstones to form.
What to do: If you suspect you have gallstones, your doctor should perform tests and may consider a different treatment.
7 DRUG INTERACTIONS No specific pharmacokinetic drug interaction studies with NEXLIZET have been conducted. Table 4 lists drug interactions with NEXLIZET that have been identified in studies with bempedoic acid or ezetimibe. Clinically Important Drug Interactions with NEXLIZET Simvastatin Clinical Impact: Concomitant use of NEXLIZET with simvastatin causes an increase in simvastatin concentration and may increase the risk of simvastatin-related myopathy [see Clinical Pharmacology (12.3) ] .
Mechanism: This combination can cause simvastatin levels to build up in your body, which increases the risk of muscle damage.
What to do: Your doctor may need to adjust your dose or monitor you closely for muscle pain.
Table 4 lists drug interactions with NEXLIZET that have been identified in studies with bempedoic acid or ezetimibe. Cyclosporine Clinical Impact: Concomitant use of NEXLIZET and cyclosporine increases ezetimibe and cyclosporine concentrations. The degree of increase in ezetimibe exposure may be greater in patients with severe renal insufficiency [see Clinical Pharmacology (12.3) ] .
Mechanism: These medicines increase each other's levels in the body, and this effect can be even stronger if you have severe kidney issues.
What to do: Your doctor should monitor your medicine levels closely, especially if you have poor kidney function.
Common Questions
What should I do if I experience muscle pain while taking Nexlizet?
Can I take Nexlizet with other cholesterol-lowering medications?
How often should I have my cholesterol levels checked while taking Nexlizet?
Can Nexlizet cause liver problems?
Is it safe to drink alcohol while taking Nexlizet?
What if I have kidney problems?
Can Nexlizet affect my blood sugar?
Are there any foods I should avoid while taking Nexlizet?
How long will I need to take Nexlizet?
What if I am taking other medications?
What are the common side effects of bempedoic acid/ezetimibe?
Does bempedoic acid/ezetimibe interact with other medications?
What drug class is bempedoic acid/ezetimibe?
Is bempedoic acid/ezetimibe safe during pregnancy?
Related Medications in ACL Inhibitor / Cholesterol Absorption Inhibitor
Other drugs grouped near bempedoic acid/ezetimibe — same-class peers and common alternatives.
alirocumab
Praluent
Praluent is a medicine that can lower cholesterol.
Compare with bempedoic acid/ezetimibe →
atorvastatin
Lipitor
Atorvastatin is a drug that lowers cholesterol and reduces the risk of heart problems and stroke.
Compare with bempedoic acid/ezetimibe →
bempedoic acid
Nexletol
Nexlizet is a combination medicine that helps lower cholesterol.
Compare with bempedoic acid/ezetimibe →
cholestyramine
Questran
Cholestyramine is a medicine that helps lower high cholesterol levels in your blood.
Compare with bempedoic acid/ezetimibe →
colestipol
Colestid
Colestipol is a drug that helps lower cholesterol levels in your blood.
Compare with bempedoic acid/ezetimibe →
Compare bempedoic acid/ezetimibe vs alirocumab side-by-side →
Medication Guides
Understanding Drug Interactions
How CYP450 enzymes, inhibitors, and inducers affect your medications
Generic vs Brand Name Drugs
FDA requirements, cost savings, and when the difference matters
Narrow Therapeutic Index Drugs
Why some drugs demand precise dosing and monitoring
Common Drug Interactions
Dangerous medication combinations and how to protect yourself
Related Health & Safety Data
🩺 Find a Doctor
Search prescribers for ACL Inhibitor / Cholesterol Absorption Inhibitor
🏨 Hospital Quality
CMS hospital ratings, safety scores & patient outcomes
💊 Supplement Data
NIH DSLD — check supplement ingredients & label claims
🍽️ Food Safety Alerts
FDA recalls, inspections & outbreak investigations
⚠️ Product Recalls
FDA, CPSC & NHTSA recall search
💉 Procedure Costs
Medicare procedure pricing for 9,297 procedures
Save on bempedoic acid/ezetimibe
Compare prices and find discounts at pharmacies near you. Free coupons can save up to 80% on prescriptions.
Disclosure: This link may earn us a commission at no extra cost to you. See our terms.
What the FDA Data Shows for bempedoic acid/ezetimibe
The FDA label for bempedoic acid/ezetimibe (sold under brand names such as Nexlizet) classifies it as a prescription-only medication in the ACL Inhibitor / Cholesterol Absorption Inhibitor class. Nexlizet is used to lower LDL-C (bad cholesterol) in adults who have high cholesterol. Official labeling lists 14 commonly reported side effects, including Upper respiratory tract infection (like a cold), Muscle spasms, High uric acid levels in the blood.
Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. For this drug, FAERS contains 329 voluntary reports. The database also lists 7 documented drug interactions derived from FDA labeling, with the top-flagged interaction rated moderate severity. NADAC pricing from CMS.
Report counts do not establish causation — a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history, and patent information further shape supply and switching decisions. This page summarizes public FDA data for educational purposes only and is not a substitute for professional medical advice — always consult a licensed healthcare provider before starting, stopping, or changing any medication.
Data Sources
Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS). Pricing: CMS National Average Drug Acquisition Cost (NADAC).
FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. Always consult a healthcare professional before making medication decisions.
Last updated: January 15, 2026
Read our methodology — how this data is sourced, computed, and verified.
All federal data sources used on this page
- FDA Orange Book — approved drug products with therapeutic equivalence. accessdata.fda.gov/cder/ob
- FDA DailyMed — NIH-hosted drug labeling for FDA-approved meds. dailymed.nlm.nih.gov
- FDA Adverse Event Reporting System (FAERS) — post-marketing safety surveillance. fda.gov/drugs/faers
- NLM RxNorm — standardized clinical drug nomenclature. nlm.nih.gov/research/umls/rxnorm
- CMS Medicare Part B Drug Average Sales Price Files — federal drug pricing data. cms.gov/medicare/part-b-drugs/asp
- FDA Drug Shortages Database — current and resolved drug shortage tracking. accessdata.fda.gov/drugshortages